Melatonin Effective for Treating Insomnia in Children with ADHD
Source: Journal of Pineal Research
Insomnia is a chronic inability to obtain or sustain sleep. While everyone occasionally experiences sleeplessness, chronic insomnia is an ongoing, often debilitating condition. After a night of inadequate sleep, those with insomnia report impaired mental and physical abilities, diminished memory, reduced alertness, and impaired reaction time. Chronic lack of sleep threatens the well being, productivity, and safety of millions of Americans. Insomnia is not a disease but a condition associated with a number of physical and emotional disorders. The incidence of insomnia is higher among people with chronic illnesses, such as hyperthyroidism, renal insufficiency, multiple sclerosis, and Alzheimer's disease. Pregnancy, alcohol intake, stress, and depression are also leading causes of insomnia.
As any parent of a child diagnosed with attention deficit hyperactivity disorder (ADHD) can tell you, coping with the daily frustrations is a challenge at best. ADHD is one of the most frequently diagnosed childhood psychiatric conditions. While there are many theories regarding the cause of ADHD, we now know that many of the children diagnosed today, have a biological parent who shares the same diagnosis. Other factors that may contribute to the symptoms of ADHD are fetal alcohol syndrome, lead poisoning, meningitis, and a genetic resistance to thyroid hormone. Also, while not a primary cause, there seems to be a positive association that exists between negative family environment factors and ADHD. A child with ADHD is unable to focus his/her attention on repetitive tasks, is easily distracted, has frequent outbursts of energy, is often fidgety, and has difficulty following instructions. Depending on the severity, a child may be considered "difficult to control." While adjusting to the symptoms that a child with ADHD displays is difficult, treatment is usually not necessary until the child enters school. When a child enters school, however, the demands for performance and consistency of behavior may accentuate the symptoms and the parent or the teacher may request testing to determine if ADHD is present.
Melatonin is a hormone that is produced by the pineal gland in the brain. For years, scientists have known that melatonin's main function was in the control of our sleep patterns. However, more recent research has revealed that it also functions as an important antioxidant. After puberty melatonin output begins a gradual steady decline. Adults experience about a 37 percent decline in daily melatonin output between the ages of 20 and 70 with the majority of the decline occurring after age 40. In 1994, melatonin became a sensation when studies revealed that supplementation provided significant life extension in several different species of laboratory animals. Although long-term studies on humans have not been conducted, melatonin became a popular product in health food stores and pharmacies throughout the country. Melatonin's primary function seems to be its role in regulating sleep/wake cycle. When darkness falls melatonin levels rise which triggers the sleep cycle.
A study published in the Journal of Pineal Research investigated the long-term melatonin treatment for effectiveness and safety in children with ADHD and chronic sleep onset insomnia (CSOI). Parents of the 94 children participating in the study were asked to answer a structured questionnaire. The follow-up was 3.7 years and no serious adverse events or treatment related co-morbidities were reported. Long-term melatonin treatment was found to be safe and effective for insomnia in 88 percent of the cases. Also, 71 percents of the children experienced improved behavior and 61 percent experienced improved mood. When melatonin treatment was discontinued, there would be a relapse of sleep onset insomnia. Researchers concluded that melatonin remains an effective therapy for long-term treatment of CSOI in children with ADHD and there are no safety concerns regarding serious adverse events or treatment related co-morbidity.1
1 Hoebert M, van der Heijden KB, van Geijlswijk IM, Smits MG. Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia. J Pineal Res. Aug2009;47(1):1-7.
E-mail Us: info@LifesourceVitamins.com
Call Us: 800.567.8122
We Are Built on Compassion - Driven by Faith & Powered by
Questions? It can be overwhelming we know. Call us, we will walk you through what
supplements will help you and which ones you really don’t need. It’s
what we do!
*Disclaimer: None of the above statements
have been evaluated by the FDA. These products are not intended to diagnose,
treat, cure or prevent any disease. As always, consult your physician before
taking any and all supplements. LifeSource Vitamins. Individual results may
Disclaimer: All the
information contained throughout this website is based upon the opinion of the
founder of LifeSource Vitamins, Bruce Brightman, and the entire team at
LifeSource Vitamins whose relentless research and studies have been ongoing on
since 1992. Other articles and
information are based on the opinions of the authors, who retains the copyright
as marked on the article. The
information on this site is not intended to replace your health care
professional, but to enhance your relationship with them. Doing your own studying and research and
taking your health care into your own hands is always best, especially in
partnership with your health care professional.
If you are pregnant, nursing, taking medications, or have any medical
conditions, always consult your health care professional before taking
supplements based on the information on this site.